Jonas Fuchs

1.1k total citations
20 papers, 243 citations indexed

About

Jonas Fuchs is a scholar working on Infectious Diseases, Immunology and Epidemiology. According to data from OpenAlex, Jonas Fuchs has authored 20 papers receiving a total of 243 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 7 papers in Immunology and 6 papers in Epidemiology. Recurrent topics in Jonas Fuchs's work include Viral Infections and Vectors (8 papers), Mosquito-borne diseases and control (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Jonas Fuchs is often cited by papers focused on Viral Infections and Vectors (8 papers), Mosquito-borne diseases and control (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Jonas Fuchs collaborates with scholars based in Germany, United States and Switzerland. Jonas Fuchs's co-authors include Georg Kochs, Marcus Panning, Gert Zimmer, Manja Marz, Friedemann Weber, Tobias Straub, Maximilian Seidl, Mirjam Schilling, Marcel A. Müller and Martin Hölzer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Virology.

In The Last Decade

Jonas Fuchs

18 papers receiving 239 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonas Fuchs Germany 9 165 54 54 53 48 20 243
Nuria Labiod Spain 7 216 1.3× 67 1.2× 56 1.0× 38 0.7× 23 0.5× 17 280
Brady T. Hickerson United States 10 265 1.6× 35 0.6× 37 0.7× 69 1.3× 50 1.0× 20 326
Andreas Schoen Germany 8 229 1.4× 105 1.9× 58 1.1× 32 0.6× 56 1.2× 14 316
Carolina Lucas United States 8 160 1.0× 51 0.9× 50 0.9× 146 2.8× 68 1.4× 12 305
Yuzy Fauzyah Japan 8 145 0.9× 24 0.4× 61 1.1× 49 0.9× 49 1.0× 10 242
Jonathan C. Guito United States 10 298 1.8× 76 1.4× 57 1.1× 59 1.1× 146 3.0× 18 463
Ariel E. Leon United States 8 111 0.7× 44 0.8× 33 0.6× 46 0.9× 29 0.6× 17 287
Lawrence Mok Australia 7 225 1.4× 77 1.4× 71 1.3× 45 0.8× 76 1.6× 10 331
Fabiana Gámbaro Uruguay 8 210 1.3× 27 0.5× 198 3.7× 43 0.8× 44 0.9× 17 456
Cécile Herrmann‐Storck Guadeloupe 11 95 0.6× 55 1.0× 25 0.5× 75 1.4× 41 0.9× 19 293

Countries citing papers authored by Jonas Fuchs

Since Specialization
Citations

This map shows the geographic impact of Jonas Fuchs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonas Fuchs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonas Fuchs more than expected).

Fields of papers citing papers by Jonas Fuchs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonas Fuchs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonas Fuchs. The network helps show where Jonas Fuchs may publish in the future.

Co-authorship network of co-authors of Jonas Fuchs

This figure shows the co-authorship network connecting the top 25 collaborators of Jonas Fuchs. A scholar is included among the top collaborators of Jonas Fuchs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonas Fuchs. Jonas Fuchs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weigang, Sebastian, et al.. (2025). SARS-CoV-2 Nsp1 Is a Major Suppressor of HLA Class I and Class II Expression. Viruses. 17(8). 1083–1083.
2.
Zimmermann, Cosima, G. M. Watson, Richard Berry, et al.. (2024). Diverse cytomegalovirus US11 antagonism and MHC-A evasion strategies reveal a tit-for-tat coevolutionary arms race in hominids. Proceedings of the National Academy of Sciences. 121(9). e2315985121–e2315985121. 3 indexed citations
3.
Dick, Alexej, Jonas Fuchs, Thiemo Sprink, et al.. (2024). Structural characterization of Thogoto Virus nucleoprotein provides insights into viral RNA encapsidation and RNP assembly. Structure. 32(8). 1068–1078.e5. 5 indexed citations
4.
Sallard, Erwan, et al.. (2024). Combining CRISPR-Cas-mediated terminal resolution with a novel genetic workflow to achieve high-diversity adenoviral libraries. Molecular Therapy — Methods & Clinical Development. 32(2). 101241–101241. 3 indexed citations
5.
Fuchs, Jonas, et al.. (2023). Bourbon virus, a newly discovered zoonotic thogotovirus. Journal of General Virology. 104(8). 7 indexed citations
6.
Wagner, Valentina, et al.. (2023). The Antiviral Activity of Equine Mx1 against Thogoto Virus Is Determined by the Molecular Structure of Its Viral Specificity Region. Journal of Virology. 97(2). e0193822–e0193822. 4 indexed citations
7.
Fuchs, Jonas, Anne Pohlmann, Kati Franzke, et al.. (2023). Disruption of influenza virus packaging signals results in various misassembled genome complexes. Journal of Virology. 97(10). e0107623–e0107623. 3 indexed citations
8.
Götz, Veronika, Daniel Hornuß, Marcus Panning, et al.. (2023). Clinical phenotype and outcome of persistent SARS-CoV-2 replication in immunocompromised hosts: a retrospective observational study in the Omicron era. Infection. 52(3). 923–933. 6 indexed citations
10.
Beer, Julius, Stefania Crotta, Angele Breithaupt, et al.. (2022). Impaired immune response drives age-dependent severity of COVID-19. The Journal of Experimental Medicine. 219(12). 27 indexed citations
11.
Weigang, Sebastian, Antje‐Christine Walz, Jonas Fuchs, et al.. (2022). Passive immunization against COVID-19 by anti-SARS-CoV-2 spike IgG in commercially available immunoglobulin preparations in severe antibody deficiency. The Journal of Allergy and Clinical Immunology In Practice. 10(9). 2452–2455.e3. 7 indexed citations
12.
Lang‐Meli, Julia, Jonas Fuchs, Hsi-en Ho, et al.. (2021). Case Series: Convalescent Plasma Therapy for Patients with COVID-19 and Primary Antibody Deficiency. Journal of Clinical Immunology. 42(2). 253–265. 23 indexed citations
13.
Fuchs, Jonas, et al.. (2020). Tick-transmitted thogotovirus gains high virulence by a single MxA escape mutation in the viral nucleoprotein. PLoS Pathogens. 16(11). e1009038–e1009038. 9 indexed citations
14.
Eiden, Sebastian, Ronald Dijkman, Roland Zell, Jonas Fuchs, & Georg Kochs. (2020). Using a mouse-adapted A/HK/01/68 influenza virus to analyse the impact of NS1 evolution in codons 196 and 231 on viral replication and virulence. Journal of General Virology. 101(6). 587–598. 3 indexed citations
15.
Hahn, Friedrich, Christina Wangen, Antonia Sophia Peter, et al.. (2020). IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro. Viruses. 12(12). 1394–1394. 41 indexed citations
16.
Fuchs, Jonas, Tobias Straub, Maximilian Seidl, & Georg Kochs. (2019). Essential Role of Interferon Response in Containing Human Pathogenic Bourbon Virus. Emerging infectious diseases. 25(7). 1304–1313. 16 indexed citations
17.
Egah, Daniel, Janis A. Müller, Nathan Y. Shehu, et al.. (2018). Low Zika virus seroprevalence among pregnant women in North Central Nigeria, 2016. Journal of Clinical Virology. 105. 35–40. 22 indexed citations
18.
Fuchs, Jonas, Martin Hölzer, Mirjam Schilling, et al.. (2017). Evolution and Antiviral Specificities of Interferon-Induced Mx Proteins of Bats against Ebola, Influenza, and Other RNA Viruses. Journal of Virology. 91(15). 46 indexed citations
19.
Fuchs, Jonas, et al.. (2017). Molecular identification of novel phlebovirus sequences in European ticks. Ticks and Tick-borne Diseases. 8(5). 795–798. 9 indexed citations
20.
Judes, C., Jonas Fuchs, & M. Jacob. (1972). Les RNA cytoplasmiques mineurs : Mise en évidence et caractérisation d'un RNA 21 S du poulet. Biochimie. 54(8). 1031–1040. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026